Showing 871-880 of 1576 results for "".
- Johnson & Johnson Vision Appoints Rajesh K. Rajpal, MD, Chief Medical Officerhttps://modernod.com/news/johnson-johnson-vision-appoints-rajesh-k-rajpal-md-chief-medical-officer/2477634/Johnson & Johnson Vision has appointed Rajesh K. Rajpal, MD, as Chief Medical Officer and Global Head of Clinical and Medical Affairs. In this role, Dr. Rajpal will lead the integration of rapidly evolving medical and clinical insights into new product development to address unmet needs of pa
- Cultivating 4-D Tissues: The Self-Curving Corneahttps://modernod.com/news/cultivating-4-d-tissues-the-self-curving-cornea/2476176/Scientists at Newcastle University have developed a biological system which lets cells form a desired shape by moulding their surrounding material—in the first instance creating a self-curving cornea. In the research, a flat circle of gel containing corneal stromal cells (stem
- Mitotech to Host Key Opinion Leader Webinar on Visomitin: A Potential Treatment for Dry Eye Diseasehttps://modernod.com/news/mitotech-to-host-key-opinion-leader-webinar-on-visomitin-a-potential-treatment-for-dry-eye-disease/2480596/Mitotech announced that it will host a key opinion leader (KOL) webinar on Visomitin and its potential for the treatment of dry eye disease, on Friday, February 4, 2022 at 8 am EST (14.00 CET). The event will feature presentations from John D. Sheppard, MD, MMSc (Virginia Eye Consu
- World Council of Optometry and Alcon Video Series Summarizes TFOS DEWS IIIhttps://modernod.com/news/world-council-of-optometry-and-alcon-video-series-summarizes-tfos-dews-iii/2486845/World Council of Optometry (WCO) and Alcon have released a series of three videos to help eye care professionals (ECPs) around the world understand and apply recommendations from the r
- Nacuity Pharmaceuticals Strengthens Scientific Advisory Board with Appointment of Nancy Holekamp, MD, and Richard L. Lindstrom, MDhttps://modernod.com/news/nacuity-pharmaceuticals-strengthens-scientific-advisory-board-with-appointment-of-nancy-holekamp-md-and-richard-l-lindstrom-md/2480903/Nacuity Pharmaceuticals announced the expansion of its Scientific Advisory Board (SAB) with the appointment of Nancy Holekamp, MD, and Richard L. Lindstrom, MD. “We are thrilled and grateful to welcome two world-renowned ophthalmologists who bring to our SAB significant and essent
- Nicox Appoints Robert N. Weinreb, MD, and Sanjay G. Asrani, MD, to its Glaucoma Clinical Advisory Boardhttps://modernod.com/news/nicox-appoints-robert-n-weinreb-md-and-sanjay-g-asrani-md-to-its-glaucoma-clinical-advisory-board/2479362/Nicox SA announced that two internationally recognized experts in glaucoma, Robert N. Weinreb, MD, Distinguished Professor and Chair, Ophthalmology and Director, Shiley Eye Institute, University of California San Diego; and Sanjay G. Asrani, MD, Professor of Ophthalmology, Duke University, will b
- Elizabeth Yeu, MD, and K. Peony Yu, MD, Appointed to Staar Surgical Board of Directorshttps://modernod.com/news/elizabeth-yeu-md-and-k-peony-yu-md-appointed-to-staar-surgical-board-of-directors/2478798/Staar Surgical announced the appointments of Elizabeth Yeu, MD, Partner, Virginia Eye Consultants, and K. Peony Yu, MD, retired Chief Medical Officer, FibroGen, to its Board of Directors, effective January 21, 2021. “The addition of Dr. Elizabeth Yeu and Dr. K. Peony Yu to our Board of Dir
- SightGlass Vision Announces R&D Webinar Featuring Leading Myopia Expertshttps://modernod.com/news/sightglass-vision-announces-rd-webinar-featuring-leading-myopia-experts/2477704/SightGlass Vision announced it will hold an R&D webinar to discuss the science of and latest research in myopia, as well as provide an overview about the clinical development and commercialization program for the company’s novel glasses designed to slow the progression of myopia in chil
- SpyGlass Pharma Raises $75 Million Series D Funding to Advance Its Long-term Drug Delivery Platform for Glaucoma Patientshttps://modernod.com/news/spyglass-pharma-raises-75-million-series-d-funding-to-advance-its-long-term-drug-delivery-platform-for-glaucoma-patients/2482829/SpyGlass Pharma announced the closing of a $75 million Series D financing round to support the development of its drug delivery platform aimed at transforming the long-term treatment of glaucoma and other chronic eye diseases.
- Sheraz Daya, MD, Introduces the Daya ICL Forcepshttps://modernod.com/news/sheraz-daya-md-introduces-the-daya-icl-forceps/2480015/In partnership with MST, Sheraz Daya, MD, has co-created an ICL loading system that ensures true confidence in loading and positioning. The design of the forceps allow the user to pull the ICL into the injection cartr